Paul B Robbins

Title: Paul B Robbins: Innovator in Cancer Treatment

Introduction

Paul B Robbins is a notable inventor based in Park City, UT (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 5 patents, Robbins has focused on developing compounds that can effectively target and reduce the proliferation of cancer cells.

Latest Patents

Robbins' latest patents include "3-aryl-substituted quinazolones, and uses thereof," which describes compounds that are useful in effectively killing or reducing the rate of proliferation of cancer cells in patients suffering from cancer. This invention not only provides the compounds themselves but also pharmaceutical compositions and methods of treatment using these compounds. Another significant patent is for "Quinoxaline derivatives as antitumor agents," which relates to methods of screening for binding partners essential for the biological activity of erastin. This invention also offers reagents and methods for the effective killing of cancer cells with erastin and related compounds or derivatives.

Career Highlights

Throughout his career, Robbins has worked with prominent organizations such as Prolexys Pharmaceuticals, Inc. and the Whitehead Institute for Biomedical Research. His work in these institutions has allowed him to advance his research and contribute to the development of innovative cancer treatments.

Collaborations

Robbins has collaborated with notable colleagues, including Robert Selliah and Longwu Qi. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Paul B Robbins is a distinguished inventor whose work in cancer treatment has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to improving patient outcomes through effective therapies.